Eugenol derivatives as potential anti-oxidants: Is phenolic hydroxyl necessary to obtain an effect?

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 5, 2014, Pages 733-746

  D'Avila Farias, Marília ^a   Oliveira, Pathise Souto ^a   Dutra, Filipe S Pereira ^a   Fernandes, Thiely Jacobsen ^a   De Pereira, Claudio M P ^a   De Oliveira, Simone Quintana ^c   Stefanello, Francieli Moro ^a   Lencina, Claiton Leonetti ^a   Barschak, Alethéa Gatto ^a,b  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

anti oxidant activity; eugenol; eugenol derivatives; phenolic compounds

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); ALKYL GROUP; ANTIOXIDANT; ARYL GROUP; BUTYLCRESOL; CARBONYL DERIVATIVE; EUGENOL DERIVATIVE; FERROUS SULFATE; HYDROGEN PEROXIDE; ORGANIC COMPOUND; PHENOL; PHENOL DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP; UNCLASSIFIED DRUG; 2,2'-AZINO-DI-(3-ETHYLBENZOTHIAZOLINE)-6-SULFONIC ACID; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; BENZOTHIAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; EUGENOL; PICRIC ACID; PLANT EXTRACT; SULFONIC ACID DERIVATIVE; THIOL DERIVATIVE;

ACYLATION; ALKYLATION; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; LIPID PEROXIDATION; LIVER HOMOGENATE; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; RAT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; EUGENIA; LIVER; METABOLISM; OXIDATIVE STRESS; PROTEIN CARBONYLATION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BENZOTHIAZOLES; BIPHENYL COMPOUNDS; CEREBRAL CORTEX; EUGENIA; EUGENOL; LIPID PEROXIDATION; LIVER; MALE; OXIDATIVE STRESS; PICRATES; PLANT EXTRACTS; PROTEIN CARBONYLATION; RATS, WISTAR; SULFHYDRYL COMPOUNDS; SULFONIC ACIDS;

EID: 84899094696     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12197     Document Type: Article

References (43)

1. Gülçin I,. Antioxidant activity of eugenol: a structure-activity relationship study. J Med Food 2011; 14: 975-985.
2. Ito M, et al. Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food Chem Toxicol 2005; 43: 461-466.
3. Escobar RG,. Eugenol: [Propriedades farmacológicas y toxicológicas, Ventajas y desvantajas de su uso.]. Rev Cubana Estomatol 2002; 39: 139-156. in Spanish.
4. Nagababu E, et al. Assessment of antioxidant activities of eugenol by in vitro and in vivo methods. Methods Mol Biol 2010; 610: 165-180.
5. Tangerino LMB. Estudo das propriedades antimicrobianas de copolímeros derivados do eugenol. Universidade Federal de Itajubá, 2006 (dissertation).
6. Prakash P, Gupta N,. Therapeutic uses of Ocimum sanctum linn (tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian J Physiol Pharmacol 2005; 49: 125-131.
7. Moreira AVB, Mancini-Filho J,. Influence of spices phenolic compounds on lipoperoxidation and lipid profile of rats tissues. Rev Nutr 2004; 17: 411-424. in Portuguese.
8. Sadeghian H, et al. Design and synthesis of eugenol derivatives, as potent 15-lipoxygenase inhibitors. Bioorg Med Chem 2008; 16: 890-901.
9. Baskaran Y, et al. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology 2010; 268: 204-212.
10. Rojo L, et al. Eugenol functionalized poly(acrylic acid) derivatives in the formation of glass-ionomer cements. Dent Mater 2008; 24: 1709-1716.
11. Carrasco HA, et al. Eugenol and its synthetic analogues inhibit cell growth of human cancer cells (part I). J Braz Chem Soc 2008; 19: 543-548.
12. Awasthi P, et al. Eugenol derivatives as future potential drugs. J Pharm Res 2008; 1: 215-220.
13. Magalhaes DV, Atividade antifúngica de derivados sintéticos do eugenol e timol frente a cepas de Candida spp. e Microsporum canis. Universidade Estadual do Ceará, 2009 (dissertation).
14. Okada N, et al. Radical modulating activity and citotoxic activity of synthesized eugenol related compounds. Anticancer Res 2000; 20: 2955-2960.
15. Hidalgo ME, et al. Antioxidant capacity of eugenol derivatives. Quim Nova 2009; 32: 1467-1470.
16. Amber K, et al. Induction of oxidative stress as a possible mechanism of the antifungal action of three phenylpropanoids. FEMS Yeast Res 2011; 11: 114-122.
17. Halliwell B,. Role of free radicals in the neurodegenerative diseases. Drugs Aging 2001; 18: 685-716.
18. Halliwell B, Gutteridge JM,. Free Radicals in Biology and Medicine, 4th edn. New York, NY: Oxford University Press, 2007.
19. Gacche R, et al. Antioxidant and anti-inflammatory related activities of selected synthetic chalcones: structure-activity relationship studies using computational tools. Chem Pharm Bull 2008; 56: 897-901.
20. Rishton GM,. Natural products as a robust source of new drugs and drug leads: past successes and presents day issues. Am J Cardiol 2008; 101: S43-S49.
21. Brand-Williams W, et al. Use of free radical method to evaluate antioxidant activity. Lebensm-Wiss Technol 1995; 28: 25-30.
22. Re R, et al. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999; 26: 1231-1237.
23. National Institute of Health. Guide for the Care and Use of Laboratory Animals, 8th edn. Washington, DC: NIH, 1996.
24. Buege JA, Aust SD,. Microssomal lipid peroxidation. Methods Enzymol 1978; 52: 302-309.
25. Aksenov MY, Markesbery WR,. Changes in thiol content and expression of glutathione redox system genes on the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 2001; 302: 141-145.
26. Stadtman ER, Levine RL,. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 2003; 25: 207-218.
27. Reznick AZ, Packer L,. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357-363.
28. Lowry OH, et al. Protein measurement with the folin phenol reagente. J Biol Chem 1951; 193: 265-275.
29. Findik E, et al. Isoeugenol-based novel potent antioxidants: synthesis and reactivity. Eur J Med Chem 2011; 46: 4618-4624.
30. Leopoldini M, et al. The molecular basis of working mechanism of natural polyphenolic antioxidants. Food Chem 2011; 125: 288-306.
31. Degáspari CH, Waszczynskyj N,. Antioxidants properties of phenolic compounds. Visão Acadêmica-Curitiba 2004; 5: 33-40. in Portuguese.
32. Cutler SJ, et al. The synthesis and biological evaluation of eugenol derivatives as potencial herbicidal agents. PGRSA 2002; 29: 93-98.
33. Fujisawa S, et al. Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology 2002; 177: 39-54.
34. Villãno D, et al. Comparison of antioxidant activity of wine phenolic compounds and metabolites in vitro. Anal Chim Acta 2005; 538: 391-398.
35. Huang W, et al. The chemistry behind antioxidant capacity assays. J Agric Food Chem 2005; 53: 1841-1856.
36. Gülçin I,. Antioxidant activity of food constituents: an overview. Arch Toxicol 2012; 86: 345-391.
37. Bortolomeazzi R, et al. Formation of dehydrodiisoeugenol and dehydrodieugenol from the reaction of isoeugenol and eugenol with DPPH radical and their role in the radical scavenging activity. Food Chem 2010; 118: 256-265.
38. Nemmiche S, et al. Cadmium chloride-induced oxidative stress and DNA damage in the human Jurkat T cell line is not linked to intracellular trace elements depletion. Toxicol in Vitro 2011; 25: 191-198.
39. Halliwell B,. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006; 97: 1634-1658.
40. Genet S, et al. Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonella foenun graecum). Mol Cell Biochem 2002; 236: 7-12.
41. Penz J, et al. Effect of 3-butyl-1-phenyl-2-(phenyltelluro)oct-en-1-one on oxidative stress in cerebral cortex of rats. Food Chem Toxicol 2009; 47: 745-751.
42. Levine RL,. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002; 32: 790-796.
43. Dalle-Donne I, et al. Protein carbonylation in human diseases. Trends Mol Med 2003; 9: 169-176. Nível Superior